B Group, Inc. is an institution, managing $86.6M across 15 long positions as of Q3 2025 with 87% Healthcare concentration, 95% concentrated in top 10 holdings, and 41% allocation to ADMA.
Largest long holdings in B Group, Inc.'s portfolio (94.6% of total portfolio)
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
Biotechnology Healthcare | $35.4M | 40.86% | +$1.4M Bought | 1.01% 2.4M shares | |
Biotechnology Healthcare | $11.0M | 12.75% | — | 0.29% 232.4K shares | |
Unknown Unknown | $9.4M | 10.80% | +$71.3K Bought | — 3.3M shares | |
Biotechnology Healthcare | $5.9M | 6.80% | — | 0.66% 1.8M shares | |
Biotechnology Healthcare | $4.5M | 5.20% | -$349.3K Sold | 2.29% 175.7K shares | |
Biotechnology Healthcare | $4.1M | 4.69% | +$752.0K Bought | 0.14% 135.0K shares | |
Biotechnology Healthcare | $3.5M | 4.09% | — | 0.92% 572.6K shares | |
Biotechnology Healthcare | $3.3M | 3.76% | — | 0.41% 1.5M shares | |
Medical - Devices Healthcare | $3.2M | 3.70% | — | 1.78% 930.0K shares | |
Biotechnology Healthcare | $1.7M | 1.94% | +$335.2K Bought | 0.17% 100.0K shares |
Portfolio activity, position movements, and quarter-over-quarter changes in B Group, Inc.'s latest filing
| Position | Shares Δ |
|---|---|
New | |
+25.0% | |
+22.73% | |
+4.1% | |
+0.77% |
| Position | Shares Δ |
|---|---|
-99.9% | |
-10.0% | |
-7.21% |
Portfolio insights and performance metrics for B Group, Inc.
We use cookies for analytics. See our Privacy and Cookie Policy.